StartsidaAPNHY • OTCMKTS
add
Aspen Pharmacare
Föregående stängning
9,42 $
Dygnsintervall
9,65 $ - 9,65 $
Årsintervall
9,42 $ - 13,69 $
Börsvärde
75,89 md ZAR
Genomsnittlig volym
174,00
Aktuellt
Ekonomi
Resultaträkning
Intäkter
Nettoinkomst
| (ZAR) | juni 2024info | Förändring Y/Y |
|---|---|---|
Intäkter | 11,78 md | 9,30 % |
Rörliga kostnader | 2,36 md | −3,24 % |
Nettoinkomst | 1,04 md | −18,17 % |
Nettovinstmarginal | 8,87 | −25,15 % |
Vinst per aktie | — | — |
EBITDA | 2,93 md | 7,80 % |
Giltig skattesats | 25,52 % | — |
Balansräkning
Totala tillgångar
Totala ansvarsskyldigheter
| (ZAR) | juni 2024info | Förändring Y/Y |
|---|---|---|
Kontanta och kortsiktiga investeringar | 12,34 md | 13,06 % |
Totala tillgångar | 139,16 md | 3,63 % |
Totala ansvarsskyldigheter | 54,29 md | 13,00 % |
Totala tillgångar | 84,86 md | — |
Utestående aktier | 444,21 mn | — |
P/B | 0,05 | — |
Avkastning på tillgångar | 4,84 % | — |
Avkastning på kapital | 5,56 % | — |
Kassaflöde
Förändring i nettokassa
| (ZAR) | juni 2024info | Förändring Y/Y |
|---|---|---|
Nettoinkomst | 1,04 md | −18,17 % |
Kontanter från verksamhet | 1,88 md | −1,21 % |
Kontanter från investering | −1,65 md | −79,92 % |
Kontanter från finansiering | −141,50 mn | 52,91 % |
Förändring i nettokassa | −200,00 mn | −118,37 % |
Fritt kassaflöde | 525,31 mn | −32,86 % |
Om
Aspen Pharmacare Holdings Limited is a public multinational pharmaceutical company headquartered in uMhlanga, South Africa. Founded in 1997, it listed on the Johannesburg Stock Exchange in 1998, and purchased South African Druggists in 1999 before expanding into international markets. Currently the largest pharmaceutical company in Africa through aggressive mergers and expansion, with major manufacturing sites in locations such as Gqeberha in South Africa, Bad Oldesloe in Germany, Notre-Dame-de-Bondeville in France, and Oss, Netherlands, Aspen is known for manufacturing and distributing branded pharmaceuticals as well as generic HIV/AIDS antiretrovirals and cancer medications. Among other products, Aspen has also been involved in manufacturing the Janssen COVID-19 vaccine through "fill and finish", and has the rights to sell the product under its own brand name Aspenovax. The company's revenue in 2022 was R38.6 billion. In 2016 Aspen was fined for high prices on cancer drugs, and after an investigation Aspen committed to reduce prices for 5 years in the European Union. Wikipedia
Grundades
1850
Huvudkontor
Hemsida
Anställda
9 109
